NCT01578278View on ClinicalTrials.gov

Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis

PHASE2CompletedINTERVENTIONAL

Enrollment

606

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions

Seasonal Allergic Rhinitis

Interventions

DRUG

Bepotastine besilate formulation

Nasal Spray

DRUG

Fluticasone propionate

Nasal Spray

DRUG

Bepotastine besilate-fluticasone propionate

Nasal Spray

DRUG

Placebo Comparator

Nasal Spray

Trial Locations (1)

92618

ISTA Pharmaceuticals, Inc., Irvine

All Listed Sponsors

lead

Bausch & Lomb Incorporated

INDUSTRY

NCT01578278 - Bepotastine Besilate-corticosteroid Nasal Spray Combination Compared to Placebo, Bepotastine Besilate Nasal Spray, and Corticosteroid Nasal Spray in the Treatment of Patients With Seasonal Allergic Rhinitis | Biotech Hunter | Biotech Hunter